4002
Use of Biomarkers in Severe Asthma
Monday, March 3, 2014: 7:00 AM-8:00 AM
Marriott South Tower, Level 3, Marina Ballroom Salon E
1.00 CME/ 1.20 CE
Primary Discussion Leaders:
Jonathan Corren , MD
Faoud T. Ishmael , MD PhD FAAAAI
Learning Objectives:
  1. Review and understand specific markers (blood and sputum eosinophils, FeNO, periostin, urine leukotrienes, EBT)
  2. Describe the relationship of these markers to specific asthma phenotypes and endotypes
  3. Explore the use of these markers as predictors of efficacies of specific therapies
Handouts
  • Biomarker 4002 1-3-14.pdf (88.4 kB)
  • See more of: Seminar